Delegat’s record operating result opens a new growth test

Record operating result masks a weaker statutory profit

Delegat Group Limited (NZX:DGL) produced its strongest underlying result on record in FY26, with operating NPAT climbing 20% to NZ$61.5 million and operating EBITDA rising 15% to NZ$134.5 million. Yet the statutory result moved in the opposite direction: reported NPAT fell 19% to NZ$39.5 million after a series of fair-value adjustments, including an impairment tied to the company’s Barossa Valley Estate assets.

The result puts a useful distinction at the centre of Delegat’s annual report. Global case sales increased 4% to 3.32 million, revenue rose 4% to NZ$364.1 million and operating margin expanded to 37% on an EBITDA basis. But the reported accounts absorbed NZ$30.9 million of pre-tax fair-value items, including a NZ$15.0 million biological produce adjustment, a NZ$7.2 million derivative write-down and the NZ$8.7 million non-cash impairment.

Oyster Bay drives growth across key markets

North America remained Delegat’s largest market, contributing 1.552 million cases, or 47% of group volumes, after 3% growth. The company said the United States completed a planned inventory reset while Canada delivered a record result. The UK, Ireland and Europe added 2% growth to 1.027 million cases, while Australia, New Zealand, China and Asia Pacific delivered the fastest regional increase, up 10% to 741,000 cases.

Delegat said Oyster Bay remains its primary growth engine and intends to concentrate further investment on consumer engagement and distribution in North America. The company’s three-year plan targets 3.6 million global cases by FY29, with North American Oyster Bay sales identified as the principal growth driver. Management also pointed to premiumisation and higher case-price realisation as potential contributors to margin improvement, although the outlook remains exposed to consumer demand, currency movements and changing wine inventories.

Cash generation cuts debt and supports dividend increase

Cash was the cleaner part of the story. Operating cash flow reached a record NZ$110.5 million, up 5%, allowing Delegat to reduce net debt by NZ$51.8 million to NZ$276.8 million. Capital expenditure fell sharply to NZ$20.9 million from NZ$59.9 million, while the group invested NZ$21.9 million in strategic projects across vineyards and wineries and returned NZ$20.2 million to shareholders through dividends.

The board approved a fully imputed dividend of 22.0 cents per share, 10% above the previous five-year payout. Delegat also reported NZ$139.8 million of available capacity within its syndicated senior debt facilities at year-end and said it met its banking covenants throughout the year. A further NZ$33.7 million of investment has been approved for FY27.

Barossa impairment exposes a weaker wine category

The impairment is non-cash, but it is not merely an accounting footnote. Delegat said current market conditions affecting premium Australian red wine, including elevated global inventory and stronger competition in export markets, reduced the recoverable value of the Barossa Valley Estate cash-generating unit to NZ$47.9 million. The company used a seven-year discounted cash-flow model, with an 11.3% pre-tax discount rate and a 2% terminal growth assumption.

The valuation remains sensitive to its inputs: Delegat said a 5% reduction in forecast case sales would cut recoverable value by NZ$3.2 million, while a 0.5 percentage-point increase in the discount rate would reduce it by NZ$4.4 million. That sensitivity leaves the performance of the Australian red-wine business a specific test for the company’s FY27 plans.

FY27 guidance leaves tariff refund unresolved

Delegat forecasts FY27 global case sales of 3.4 million and operating NPAT between NZ$62 million and NZ$66 million. The range implies continued operating growth, but it does not include a potential refund of US tariffs estimated at US$9.1 million, or NZ$16.1 million. No asset has been recognised because the relevant distributors must first receive refunds from US Customs and Border Protection and then agree to remit amounts to Delegat, leaving both timing and recovery uncertain.

The immediate question is whether the company can convert a strong premium New Zealand wine franchise into another year of operating growth while containing the weaker economics of Barossa Valley Estate. FY27’s harvest, North American case volumes and the quality of cash conversion will provide a more consequential answer than the headline dividend alone.